Table 6 Glycemic control and glucose-lowering therapy for pregnant women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) in Kronoberg

HbA1c 1^st trimester (mmol/mol)

56 ± 15

49 ± 14

(Min/max)

32–113

35–73

HbA1c 2^nd trimester (mmol/mol)

49 ± 12

42 ± 6

(Min-max)

31–82

36–52

HbA1c 3^rd trimester (mmol/mol)

48 ± 11.1

42 ± 7

(Min-max)

29–80

34–54

Type of therapy (insulin^a vs diet)

36 (97%)

8 (73%)

Daily dose of basal (weeks 26–28) (units)

28 ± 20.2

25 ± 40.2

Daily dose of basal at (delivery) (units)

32 ± 21.8

31 ± 39.2

Daily dose of bolus (weeks 26–28) (units)

48 ± 29.4

26 ± 27.4

Daily dose of bolus at (delivery) (units)

57 ± 31.3

40 ± 34